Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats

Nutrition and Cancer

Volumn 60, Issue 5, 2008, Pages 660-665

  Liu, Yingying ^a   Ju, Jihyeung ^a   Xiao, Hang ^a   Simi, Barbara ^a   Hao, Xingpei ^a   Reddy, Bandaru S ^a   Huang, Mou Tuan ^a   Newmark, Harold ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZOXYMETHANE; CALCIUM; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COLON; COLON ABERRANT CRYPT FOCI; COLON DISEASE; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; DIET; DIET THERAPY; FEMALE; LIPID DIET; MALE; MOUSE; NONHUMAN; RAT; RISK REDUCTION; SHAM FEEDING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; AZOXYMETHANE; CALCIUM, DIETARY; CARCINOGENS; COLON; COLONIC NEOPLASMS; DIETARY FATS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; MALE; MICE; RATS;

MUS; RATTUS;

EID: 51849153816     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802290215     Document Type: Article

References (35)

1. World Cancer Report, Stewart BW and Kleihues P (eds.). World Health Organization and International Association of Research on Cancer, 2003.
2. Yiu HY, Whittemore AS, and Shibata A: Increasing colorectal cancer incidence rates in Japan. Int J Cancer 109, 777-781, 2004.
3. Kono S: Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev 13, 127-132, 2004.
4. McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, et al.: Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14, 1-12, 2003.
5. Wu K, Willett WC, Fuchs CS, Colditz GA, and Giovannucci EL: Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94, 437-446, 2002.
6. Kampman E, Slattery ML, Caan B and Potter JD: Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11, 459-466, 2000.
7. Peters U, Chatterjee N, McGlynn KA, Schoen RE, Church TR, et al.: Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr 80, 1358-1365, 2004.
8. Sellers TA, Bazyk AE, Bostick RM, Kushi LH, Olson JE, et al.: Diet and risk of colon cancer in a large prospective study of older women: an analysis stratified on family history (Iowa, United States). Cancer Causes Control 9, 357-367, 1998.
9. Thun MJ, Henley SJ, and Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents:mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94, 252-266, 2002.
10. Thun MJ, Namboodiri MM, and Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325, 1593-1596, 1991.
11. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, et al.: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121, 241-246, 1994.
12. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, et al.: Aspirin and the risk of colorectal cancer in women. N Engl J Med 333, 609-614, 1995.
13. Smalley W, Ray WA, Daugherty J, and Griffin MR: Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 159, 161-166, 1999.
14. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, et al.: Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340, 101-107, 1999.
15. Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, et al.: Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 96, 921-925, 2004.
16. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, et al.: Arandomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348, 883-890, 2003.
17. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, et al.: A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348, 891-899, 2003.
18. Grau MV, Baron JA, Barry EL, Sandler RS, Haile RW, et al.: Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 14, 2353-2358, 2005.
19. Pence BC, Dunn DM, Zhao C, Landers M, and Wargovich MJ: Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis 16, 757-765, 1995.
20. Molck AM, Poulsen M, and Meyer O: The combination of 1 alpha,25(OH2)-vitamin D3, calcium and acetylsalicylic acid affects azoxymethane-induced aberrant crypt foci and colorectal tumours in rats. Cancer Lett 186, 19-28, 2002.
21. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, and Steele VE: Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15, 1049-1054, 1994.
22. Sesink AL, Termont DS, Kleibeuker JH, and Van der Meer R: Red meat and colon cancer: dietary haem-induced colonic cytotoxicity and epithelial hyperproliferation are inhibited by calcium. Carcinogenesis 22, 1653-1659, 2001.
23. Shpitz B, Bomstein Y, Kariv N, Shalev M, Buklan G, et al.: Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. Int J Colorectal Dis 13, 169-172, 1998.
24. Mahmoud NN, Dannenberg AJ, Mestre J, Bilinski RT, Churchill MR, et al.: Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery 124, 225-231, 1998.
25. Laprise P, Langlois MJ, Boucher MJ, Jobin C, and Rivard N: Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol 199, 32-39, 2004.
26. Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, et al.: Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect Prev 24, 127-136, 2000.
27. Lamprecht SA and Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3, 601-614, 2003.
28. Jiang MC, Liao CF, and Lee PH: Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun 282, 671-677, 2001.
29. Stark LA, Din FV, Zwacka RM, and Dunlop MG: Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 15, 1273-1275, 2001.
30. Dong Z, Huang C, Brown RE, and Ma WY: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272, 9962-9970, 1997.
31. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-151, 1987.
32. Doi K, Wanibuchi H, Salim EI, Morimura K, Kinoshita A, et al.: Lack of large intestinal carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine at low doses in rats initiated with azoxymethane. Int J Cancer 115, 870-878, 2005.
33. Newmark HL, Heaney RP, and Lachance PA: Should calcium and vitamin D be added to the current enrichment program for cereal-grain products? Am J Clin Nutr 80, 264-270, 2004.
34. Newmark HL: Nutrient density: an important and useful tool for laboratory animal studies. Carcinogenesis 8, 871-873,1987.
35. Food and Nutrition Board: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1997.